FreshLeaf Analytics has released a comprehensive report on the current status of the Australian medicinal cannabis market

FreshLeaf reveals medicinal cannabis report

FreshLeaf Analytics has released a comprehensive report on the current status of the Australian medicinal cannabis market. The FreshLeaf H1 2021 product, pricing and patient analysis report found that the last six months were defined by intense medicinal cannabis product competition, keeping downward pressure on prices. The report has also been welcomed by the sector.Cassandra Hunt, Managing Director...
Read More
Australia cannabis industry could grow to $1.5b per year

Australian cannabis industry could make $1.5b per year

An industry report has warned Australia risks losing a billion dollar industry. Australia risks losing a billion dollar industry if medicinal cannabis is not correctly regulated, an industry report has warned.The report, published by FreshLeaf Analytics, forecasts Australia’s medicinal cannabis industry will double in size from $100m to $200m by the end of the year.Currently...
Read More
bottle of oil Cannabis in pipette in hand, CBD cannabis OIL on white background, medical marijuana concept, close up, hemp product,

Low-Dose CBD Oil Can Now Be Bought Over-the-Counter

You no longer need a prescription to get low-dose cannabidiol, though it’ll be months before approved products hit the shelves. And no, you can’t get high from it. We answer some common questions about the medicinal product. Last December, Australia’s Therapeutic Goods Administration (TGA) made a big announcement: it was “down-scheduling” or easing access to certain...
Read More

‘We know it works’: Cannabis oil firms chase approvals as over-the-counter sales are legalised

Cannabis oil firms chase approvals as over-the-counter sales are legalised Low dose cannabis oil can be bought over the counter at pharmacies from Monday for the first time, but don’t expect to find any for at least six months as none has been approved for sale yet.Manufacturers are working at a “lightning” rate to get...
Read More
Medicinal cannabis stocks

Score check: Here’s how ASX pot stocks have responded to the US Senate result

Score check: Here’s how ASX pot stocks have responded to the US Senate result As ever, US politics is full of surprises — and ASX cannabis stocks have benefitted in Wednesday trade.The Democrats won both seats in the Georgia runoff Senate races, giving them the narrowest of governing majorities in the Senate.It’s viewed as broadly...
Read More
Freshleaf Analytics

2021 is giving us over-the-counter medical cannabis

From early 2021 you’ll technically be allowed to buy low-dose cannabis oil from pharmacies without a prescription.However, while the laws have been changed so you can buy CBD oil over-the-counter, there are currently no products approved for sale.Firstly, these products won’t get you high. This is only low-dose CBD oil we’re talking about and products...
Read More
FreshLeaf has access to full product details for most medicinal cannabis products available in the marketplace in Australia.

ASX pot stocks are getting high after TGA interim ruling

Stockhead Cannabis stocks were one of the rare groups in the green on a dismal day for the ASX on Wednesday following an interim ruling by the Therapeutic Goods Administration that could boost the industry. The TGA is proposing to allow Australians to obtain low-dose cannabinoid (CBD) oils and pills from pharmacists, rather than forcing them to...
Read More
Here’s how Australia could reap the benefits from a stricter regulatory cannabis framework

Here’s how Australia could reap the benefits from a stricter regulatory cannabis framework

Publication: Stockhead   Here’s how Australia could reap the benefits from a stricter regulatory cannabis framework
Read More
1 2